Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15894548rdf:typepubmed:Citationlld:pubmed
pubmed-article:15894548lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:15894548lifeskim:mentionsumls-concept:C0007113lld:lifeskim
pubmed-article:15894548lifeskim:mentionsumls-concept:C0332174lld:lifeskim
pubmed-article:15894548lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:15894548lifeskim:mentionsumls-concept:C0069717lld:lifeskim
pubmed-article:15894548lifeskim:mentionsumls-concept:C1517927lld:lifeskim
pubmed-article:15894548lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:15894548lifeskim:mentionsumls-concept:C0445204lld:lifeskim
pubmed-article:15894548lifeskim:mentionsumls-concept:C0444889lld:lifeskim
pubmed-article:15894548lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:15894548lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:15894548pubmed:issue7lld:pubmed
pubmed-article:15894548pubmed:dateCreated2005-6-20lld:pubmed
pubmed-article:15894548pubmed:abstractTextOxaliplatin (OXA) significantly enhanced the antitumour activity of 5-fluorouracil (FUra) in patients with advanced colorectal cancer and displayed radiosensitising properties in preclinical studies. This study was thus performed to test the feasibility, identify the recommended doses (RDs) and explore preliminarily the clinical activity of weekly OXA and infused FUra combined with preoperative pelvic radiotherapy.lld:pubmed
pubmed-article:15894548pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15894548pubmed:languageenglld:pubmed
pubmed-article:15894548pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15894548pubmed:citationSubsetIMlld:pubmed
pubmed-article:15894548pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15894548pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15894548pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15894548pubmed:statusMEDLINElld:pubmed
pubmed-article:15894548pubmed:monthJullld:pubmed
pubmed-article:15894548pubmed:issn0923-7534lld:pubmed
pubmed-article:15894548pubmed:authorpubmed-author:FabrisGGlld:pubmed
pubmed-article:15894548pubmed:authorpubmed-author:MonfardiniSSlld:pubmed
pubmed-article:15894548pubmed:authorpubmed-author:LiseMMlld:pubmed
pubmed-article:15894548pubmed:authorpubmed-author:SottiGGlld:pubmed
pubmed-article:15894548pubmed:authorpubmed-author:AscheleCClld:pubmed
pubmed-article:15894548pubmed:authorpubmed-author:Del BiancoPPlld:pubmed
pubmed-article:15894548pubmed:authorpubmed-author:PucciarelliSSlld:pubmed
pubmed-article:15894548pubmed:authorpubmed-author:FrisoM LMLlld:pubmed
pubmed-article:15894548pubmed:authorpubmed-author:LonardiSSlld:pubmed
pubmed-article:15894548pubmed:authorpubmed-author:SartorLLlld:pubmed
pubmed-article:15894548pubmed:authorpubmed-author:UrsoE D LEDlld:pubmed
pubmed-article:15894548pubmed:issnTypePrintlld:pubmed
pubmed-article:15894548pubmed:volume16lld:pubmed
pubmed-article:15894548pubmed:ownerNLMlld:pubmed
pubmed-article:15894548pubmed:authorsCompleteYlld:pubmed
pubmed-article:15894548pubmed:pagination1140-6lld:pubmed
pubmed-article:15894548pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15894548pubmed:meshHeadingpubmed-meshheading:15894548...lld:pubmed
pubmed-article:15894548pubmed:meshHeadingpubmed-meshheading:15894548...lld:pubmed
pubmed-article:15894548pubmed:meshHeadingpubmed-meshheading:15894548...lld:pubmed
pubmed-article:15894548pubmed:meshHeadingpubmed-meshheading:15894548...lld:pubmed
pubmed-article:15894548pubmed:meshHeadingpubmed-meshheading:15894548...lld:pubmed
pubmed-article:15894548pubmed:meshHeadingpubmed-meshheading:15894548...lld:pubmed
pubmed-article:15894548pubmed:meshHeadingpubmed-meshheading:15894548...lld:pubmed
pubmed-article:15894548pubmed:meshHeadingpubmed-meshheading:15894548...lld:pubmed
pubmed-article:15894548pubmed:meshHeadingpubmed-meshheading:15894548...lld:pubmed
pubmed-article:15894548pubmed:meshHeadingpubmed-meshheading:15894548...lld:pubmed
pubmed-article:15894548pubmed:meshHeadingpubmed-meshheading:15894548...lld:pubmed
pubmed-article:15894548pubmed:meshHeadingpubmed-meshheading:15894548...lld:pubmed
pubmed-article:15894548pubmed:meshHeadingpubmed-meshheading:15894548...lld:pubmed
pubmed-article:15894548pubmed:meshHeadingpubmed-meshheading:15894548...lld:pubmed
pubmed-article:15894548pubmed:year2005lld:pubmed
pubmed-article:15894548pubmed:articleTitleA phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer.lld:pubmed
pubmed-article:15894548pubmed:affiliationDepartment of Medical Oncology, Radiotherapy and Surgery, Padova University Hospital, Padova. aschele@tin.itlld:pubmed
pubmed-article:15894548pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15894548pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15894548pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15894548pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
pubmed-article:15894548pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15894548lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15894548lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15894548lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15894548lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15894548lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15894548lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15894548lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15894548lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15894548lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15894548lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15894548lld:pubmed